4.79
price down icon1.24%   -0.06
after-market Dopo l'orario di chiusura: 4.76 -0.03 -0.63%
loading

Vanda Pharmaceuticals Inc Azioni (VNDA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
4.84%
47.46
45.27 38.81 46.06 62.50
Operating Expenses
8.27%
56.70
52.37 44.81 48.92 60.49
Benefits Costs and Expenses
11.07%
52.13
46.93 38.94 43.46 56.97
Costs And Expenses
8.27%
56.70
52.37 44.81 48.92 60.49
Operating Income/Loss
30.18%
-9.235
-7.094 -5.995 -2.867 2.004
Income/Loss From Continuing Operations Before Tax
180.79%
-4.664
-1.661 -0.12 2.592 5.528
Income Tax Expense/Benefit, Deferred
96.71%
-0.246
-7.484 2.729 1.455 2.014
Income Tax Expense/Benefit
170.09%
-0.518
0.739 -0.257 1.072 2.276
Income/Loss From Continuing Operations After Tax
72.75%
-4.146
-2.40 0.137 1.52 3.252
Net Income/Loss
72.75%
-4.146
-2.40 0.137 1.52 3.252
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
113.14K%
57.76
0.051 57.52 57.45 57.01
Diluted Average Shares
126.33K%
57.76
0.0457 57.60 57.54 57.40
Basic Earnings Per Share
40.00%
-0.07
-0.05 - 0.03 0.06
Diluted Earnings Per Share
40.00%
-0.07
-0.05 - 0.03 0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):